🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Clinical trial phase I, randomized, double blind, where 30 individuals will...
Status
Completed
Location
Unidade de Ensaios Clínicos para Imunobiológicos
Start Date
2014-05
Trial ID
NCT01889836
Treatments Being Tested
The purpose of this study is to conduct long-term surveillance for efficacy...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-09-18
Trial ID
NCT02207816
The purpose of this study is: To assess whether there are differences in a...
Status
Completed
Location
Health Protection Agency
Start Date
2008-02
Trial ID
NCT00625677
Treatments Being Tested
A previous cohort of 93 clinical trial participants received quadrivalent m...
Status
Completed
Location
Multiple Locations
Start Date
2016-12
Trial ID
NCT02811120
Treatments Being Tested
In the UK, infants currently receive a 5-in-1 vaccine (Pediacel) at 2, 3 an...
Status
Completed
Location
St George's Vaccien Institute
Start Date
2013-07
Trial ID
NCT01896596
The purpose of this study is to evaluate immunogenicity and safety of menin...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-01
Trial ID
NCT01144663
Treatments Being Tested
The purpose of the study is to evaluate the immune responses of UK infants ...
Status
Completed
Location
Hertfordshire Primary Care Trusts
Start Date
2005-04
Trial ID
NCT00197808
Treatments Being Tested
This study was aimed to explore safety and immunogenicity of two formulatio...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00381615
The study will include groups of adults, toddlers, and infants who will rec...
Status
Completed
Location
Multiple Locations
Start Date
2006-07-25
Trial ID
NCT06165276
The purpose of this observer-blind study is to gather key efficacy, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-27
Trial ID
NCT00866619